Dan Hutcheson - Publications


10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Halbout B, Quarta D, Valerio E, Heidbreder CA, Hutcheson DM. The GABA-B positive modulator GS39783 decreases psychostimulant conditioned-reinforcement and conditioned-reward. Addiction Biology. 16: 416-27. PMID 21309927 DOI: 10.1111/J.1369-1600.2010.00278.X  0.616
2011 Hutcheson DM, Quarta D, Halbout B, Rigal A, Valerio E, Heidbreder C. Orexin-1 receptor antagonist SB-334867 reduces the acquisition and expression of cocaine-conditioned reinforcement and the expression of amphetamine-conditioned reward. Behavioural Pharmacology. 22: 173-81. PMID 21285875 DOI: 10.1097/Fbp.0B013E328343D761  0.64
2010 Quarta D, Valerio E, Hutcheson DM, Hedou G, Heidbreder C. The orexin-1 receptor antagonist SB-334867 reduces amphetamine-evoked dopamine outflow in the shell of the nucleus accumbens and decreases the expression of amphetamine sensitization. Neurochemistry International. 56: 11-5. PMID 19737591 DOI: 10.1016/j.neuint.2009.08.012  0.394
2008 Woolley ML, Waters KA, Reavill C, Bull S, Lacroix LP, Martyn AJ, Hutcheson DM, Valerio E, Bate S, Jones DN, Dawson LA. Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat. Behavioural Pharmacology. 19: 765-76. PMID 19020411 DOI: 10.1097/FBP.0b013e32831c3b06  0.335
2007 Everitt BJ, Hutcheson DM, Ersche KD, Pelloux Y, Dalley JW, Robbins TW. The orbital prefrontal cortex and drug addiction in laboratory animals and humans. Annals of the New York Academy of Sciences. 1121: 576-97. PMID 17846151 DOI: 10.1196/Annals.1401.022  0.616
2007 Halbout B, Hutcheson D, Melotto S, Heidbreder C. P.2.22 Baclofen decreases instrumental response and cue-induced reinstatement for a cocaine-conditioned reinforcer European Neuropsychopharmacology. 17: S56-S57. DOI: 10.1016/S0924-977X(07)70067-6  0.424
2004 Tessari M, Pilla M, Andreoli M, Hutcheson DM, Heidbreder CA. Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking. European Journal of Pharmacology. 499: 121-33. PMID 15363959 DOI: 10.1016/j.ejphar.2004.07.056  0.37
2003 Hutcheson DM, Everitt BJ. The effects of selective orbitofrontal cortex lesions on the acquisition and performance of cue-controlled cocaine seeking in rats. Annals of the New York Academy of Sciences. 1003: 410-1. PMID 14684474 DOI: 10.1196/annals.1300.038  0.545
2001 Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nature Neuroscience. 4: 943-7. PMID 11528427 DOI: 10.1038/nn0901-943  0.562
2001 Hutcheson DM, Parkinson JA, Robbins TW, Everitt BJ. The effects of nucleus accumbens core and shell lesions on intravenous heroin self-administration and the acquisition of drug-seeking behaviour under a second-order schedule of heroin reinforcement. Psychopharmacology. 153: 464-72. PMID 11243494 DOI: 10.1007/s002130000635  0.596
Show low-probability matches.